Jul 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2023 Jun 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.19 1.24 5.20
(-4.2 pct) (+6.1 pct) (+5.6 pct)
Operating 209 mln 292 mln 850 mln
(-28.5 pct) (+4.8 pct) (+3.5 pct)
Recurring 210 mln 298 mln 850 mln
(-29.5 pct) (+6.1 pct) (-0.5 pct)
Net 143 mln 201 mln 570 mln
(-28.6 pct) (+4.3 pct) (+0.3 pct)
EPS 34.48 yen 48.28 yen 136.56 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T